{"id":"NCT00290342","sponsor":"GlaxoSmithKline","briefTitle":"Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants","officialTitle":"A Multicentric Study to Compare the Immunogenicity, Safety & Reactogenicity of GSK Biologicals' DTPa-IPV Vaccine vs. Co-administration of GSK's DTPa Vaccine & Sanofi-Pasteurs' IPV Vaccine at Different Injection Sites, to Healthy Children","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01-01","primaryCompletion":"2007-01-01","completion":"2007-01-23","firstPosted":"2006-02-13","resultsPosted":"2018-10-29","lastUpdate":"2018-10-29"},"enrollment":458,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Tetanus","Acellular Pertussis","Diphtheria"],"interventions":[{"type":"BIOLOGICAL","name":"DTPa-IPV","otherNames":["Infanrix™-IPV"]},{"type":"BIOLOGICAL","name":"DTPa","otherNames":["Infanrix™"]},{"type":"BIOLOGICAL","name":"IMOVAX Polio®","otherNames":[]}],"arms":[{"label":"Infanrix-IPV Group","type":"EXPERIMENTAL"},{"label":"Infanrix + IMOVAX Polio Group","type":"ACTIVE_COMPARATOR"}],"summary":"DTPa and IPV vaccines are recommended for immunization of infants in Korea. The use of combination vaccines simplifies routine paediatric vaccination. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Number of Seroprotected Subjects Against Diphtheria (Anti-D) and Tetanus (Anti-T)","timeFrame":"One month (Month 5) post-primary vaccination course","effectByArm":[{"arm":"Infanrix-IPV Group","deltaMin":204,"sd":null},{"arm":"Infanrix + IMOVAX Polio Group","deltaMin":211,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"8 Weeks","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":17},"locations":{"siteCount":9,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":224},"commonTop":["Irritability","Erythema","Somnolence","Pain","Decreased appetite"]}}